(RTTNews) - Healthcare technology firm Medtronic plc (MDT) announced Wednesday the U.S. Food and Drug Administration (FDA) clearance for its new InPen app featuring missed meal dose detection, paving ...

New Smart MDI system will be the first system to deliver real-time, personalized insights on when and how much to dose including for missed or inaccurate mealtime doses. GALWAY, Ireland, Nov. 20, 2024 ...

This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. Medtronic received Food and Drug Administration clearance ...

SAN DIEGO, July 9, 2018 /PRNewswire/ -- Companion Medical, a leader in the development of advanced technology to improve diabetes care, has received FDA clearance for the Android version of its InPen™ ...

Medtronic plc MDT recently received Food and Drug Administration (“FDA”) clearance for its new InPen app, which features missed meal dose detection. This latest FDA clearance should pave the way for ...

Please provide your email address to receive an email when new articles are posted on . The FDA has granted clearance for the Android version of the InPen app, making ...

Medtronic (MDT) announced FDA clearance for its new InPen app featuring missed meal dose detection, paving the way for the launch of its Smart MDI system with the Simplera continuous glucose monitor, ...